These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
303 related articles for article (PubMed ID: 23382045)
21. TGFBI Expression in Cancer Stromal Cells is Associated with Poor Prognosis and Hematogenous Recurrence in Esophageal Squamous Cell Carcinoma. Ozawa D; Yokobori T; Sohda M; Sakai M; Hara K; Honjo H; Kato H; Miyazaki T; Kuwano H Ann Surg Oncol; 2016 Jan; 23(1):282-9. PubMed ID: 25448803 [TBL] [Abstract][Full Text] [Related]
22. Activin a causes cancer cell aggressiveness in esophageal squamous cell carcinoma cells. Yoshinaga K; Yamashita K; Mimori K; Tanaka F; Inoue H; Mori M Ann Surg Oncol; 2008 Jan; 15(1):96-103. PubMed ID: 17909904 [TBL] [Abstract][Full Text] [Related]
23. Isolation and phenotypic characterization of colorectal cancer stem cells with organ-specific metastatic potential. Gao W; Chen L; Ma Z; Du Z; Zhao Z; Hu Z; Li Q Gastroenterology; 2013 Sep; 145(3):636-46.e5. PubMed ID: 23747337 [TBL] [Abstract][Full Text] [Related]
24. Association of matrilysin-2 (MMP-26) expression with tumor progression and activation of MMP-9 in esophageal squamous cell carcinoma. Yamamoto H; Vinitketkumnuen A; Adachi Y; Taniguchi H; Hirata T; Miyamoto N; Nosho K; Imsumran A; Fujita M; Hosokawa M; Hinoda Y; Imai K Carcinogenesis; 2004 Dec; 25(12):2353-60. PubMed ID: 15333466 [TBL] [Abstract][Full Text] [Related]
25. MiR-106b promotes migration and invasion through enhancing EMT via downregulation of Smad 7 in Kazakh's esophageal squamous cell carcinoma. Dai F; Liu T; Zheng S; Liu Q; Yang C; Zhou J; Chen Y; Sheyhidin I; Lu X Tumour Biol; 2016 Nov; 37(11):14595-14604. PubMed ID: 27619676 [TBL] [Abstract][Full Text] [Related]
26. miR-214 inhibits invasion and migration via downregulating GALNT7 in esophageal squamous cell cancer. Lu Q; Xu L; Li C; Yuan Y; Huang S; Chen H Tumour Biol; 2016 Nov; 37(11):14605-14614. PubMed ID: 27619677 [TBL] [Abstract][Full Text] [Related]
28. MiR-142-3p as a potential prognostic biomarker for esophageal squamous cell carcinoma. Lin RJ; Xiao DW; Liao LD; Chen T; Xie ZF; Huang WZ; Wang WS; Jiang TF; Wu BL; Li EM; Xu LY J Surg Oncol; 2012 Feb; 105(2):175-82. PubMed ID: 21882196 [TBL] [Abstract][Full Text] [Related]
29. SSEA-3 as a novel amplifying cancer cell surface marker in colorectal cancers. Suzuki Y; Haraguchi N; Takahashi H; Uemura M; Nishimura J; Hata T; Takemasa I; Mizushima T; Ishii H; Doki Y; Mori M; Yamamoto H Int J Oncol; 2013 Jan; 42(1):161-7. PubMed ID: 23175153 [TBL] [Abstract][Full Text] [Related]
30. [Expression of IGF-1R in esophageal squamous cell carcinoma and the effect of its silencing by siRNA on the proliferation of esophageal cancer EC9706 cells in vitro]. Ma W; Li W; Fan QX; Wang LX; Wang RL; Lu SX Zhonghua Zhong Liu Za Zhi; 2011 Aug; 33(8):609-12. PubMed ID: 22325222 [TBL] [Abstract][Full Text] [Related]
31. Clinical and prognostic significance of RhoA and RhoC gene expression in esophageal squamous cell carcinoma. Faried A; Faried LS; Usman N; Kato H; Kuwano H Ann Surg Oncol; 2007 Dec; 14(12):3593-601. PubMed ID: 17896152 [TBL] [Abstract][Full Text] [Related]
32. Prognostic significance of fascin overexpression in human esophageal squamous cell carcinoma. Hashimoto Y; Ito T; Inoue H; Okumura T; Tanaka E; Tsunoda S; Higashiyama M; Watanabe G; Imamura M; Shimada Y Clin Cancer Res; 2005 Apr; 11(7):2597-605. PubMed ID: 15814639 [TBL] [Abstract][Full Text] [Related]
33. Notch and Wnt/β-catenin signaling pathway play important roles in activating liver cancer stem cells. Wang R; Sun Q; Wang P; Liu M; Xiong S; Luo J; Huang H; Du Q; Geller DA; Cheng B Oncotarget; 2016 Feb; 7(5):5754-68. PubMed ID: 26735577 [TBL] [Abstract][Full Text] [Related]
34. Transforming growth factor-beta1 promotes the migration and invasion of sphere-forming stem-like cell subpopulations in esophageal cancer. Yue D; Zhang Z; Li J; Chen X; Ping Y; Liu S; Shi X; Li L; Wang L; Huang L; Zhang B; Sun Y; Zhang Y Exp Cell Res; 2015 Aug; 336(1):141-9. PubMed ID: 26096658 [TBL] [Abstract][Full Text] [Related]
35. The properties of tumor-initiating cells from a hepatocellular carcinoma patient's primary and recurrent tumor. Xu XL; Xing BC; Han HB; Zhao W; Hu MH; Xu ZL; Li JY; Xie Y; Gu J; Wang Y; Zhang ZQ Carcinogenesis; 2010 Feb; 31(2):167-74. PubMed ID: 19897602 [TBL] [Abstract][Full Text] [Related]
36. Tumor-derived tenascin-C promotes the epithelial-mesenchymal transition in colorectal cancer cells. Takahashi Y; Sawada G; Kurashige J; Matsumura T; Uchi R; Ueo H; Ishibashi M; Takano Y; Akiyoshi S; Iwaya T; Eguchi H; Sudo T; Sugimachi K; Yamamoto H; Doki Y; Mori M; Mimori K Anticancer Res; 2013 May; 33(5):1927-34. PubMed ID: 23645740 [TBL] [Abstract][Full Text] [Related]
37. Girdin, a regulator of cell motility, is a potential prognostic marker for esophageal squamous cell carcinoma. Shibata T; Matsuo Y; Shamoto T; Hirokawa T; Tsuboi K; Takahashi H; Ishiguro H; Kimura M; Takeyama H; Inagaki H Oncol Rep; 2013 Jun; 29(6):2127-32. PubMed ID: 23588413 [TBL] [Abstract][Full Text] [Related]
39. PKC iota promotes cellular proliferation by accelerated G1/S transition via interaction with CDK7 in esophageal squamous cell carcinoma. Ni S; Chen L; Li M; Zhao W; Shan X; Wu M; Cheng J; Liang L; Wang Y; Jiang W; Zhang J; Ni R Tumour Biol; 2016 Oct; 37(10):13799-13809. PubMed ID: 27481515 [TBL] [Abstract][Full Text] [Related]
40. The expression of stem cell protein Piwil2 and piR-932 in breast cancer. Zhang H; Ren Y; Xu H; Pang D; Duan C; Liu C Surg Oncol; 2013 Dec; 22(4):217-23. PubMed ID: 23992744 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]